Myofibrillar Myopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Three hours after exercise, 191 genes were identified as differentially expressed (DE) in MFM vs. control muscle with >1 log<sub>2</sub> fold change (FC) in genes involved in sulfur compound/cysteine metabolism such as cystathionine-beta-synthase ( CBS, ↓4.51), a cysteine and neutral amino acid membrane transporter ( SLC7A10, ↓1.80 MFM), and a cationic transporter (SLC24A1, ↓1.11 MFM).
|
30289745 |
2018 |
Retinal Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We report the association of many previously unreported variants with retinal disease, as well as new disease phenotypes associated with known genes, including the first association of the SLC24A1 gene with retinitis pigmentosa.
|
27624628 |
2016 |
Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We also analyzed two mutations in a Drosophila NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity.
|
27129268 |
2016 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits.
|
22560525 |
2012 |
Corpuscular Hemoglobin Concentration Mean
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
Nyctalopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Reduced visual acuity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe myopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blindness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of optic disc
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of macular pigmentation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Retinitis Pigmentosa
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We report the association of many previously unreported variants with retinal disease, as well as new disease phenotypes associated with known genes, including the first association of the SLC24A1 gene with retinitis pigmentosa.
|
27624628 |
2016 |
Retinitis Pigmentosa
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cerebral Hemorrhage
|
0.200 |
Biomarker
|
phenotype |
RGD |
Alteration of intracellular calcium and its modulator SLC24A6 after experimental intracerebral hemorrhage.
|
23564126 |
2013 |
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Night Blindness, Congenital Stationary, Type 1A
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|